Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUTCHMED

23.760
+0.5002.15%
Volume:9.43M
Turnover:223.37M
Market Cap:20.72B
PE:69.29
High:24.060
Open:23.260
Low:22.900
Close:23.260
52wk High:30.750
52wk Low:18.360
Shares:872.00M
HK Float Shares:872.00M
Volume Ratio:1.85
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.343
ROE:46.90%
ROA:-0.81%
PB:2.17
PE(LYR):69.29
PS:4.43

Loading ...

HUTCHMED (00013) Holds Investor Meeting to Share Latest R&D Progress and Pipeline Updates

Stock News
·
10 hours ago

HUTCHMED Unveils Promising ATTC Platform and Advances Lead Cancer Candidate HMPL-A251

Reuters
·
10 hours ago

HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event

GlobeNewswire
·
10 hours ago

HUTCHMED (China) Limited (13) Highlights Preclinical HMPL-A251 Data at International Oncology Conference

Bulletin Express
·
Oct 23

HUTCHMED (00013) Unveils HMPL-A251 Data at AACR-NCI-EORTC Conference

Stock News
·
Oct 23

HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire
·
Oct 23

HUTCHMED (SEHK:13) Announces Vesting of LTIP Awards

Bulletin Express
·
Oct 21

HUTCHMED China Ltd files list of directors to HKEX

Reuters
·
Oct 15

HUTCHMED (00013): Professor Chen Shaowen Appointed as Independent Non-Executive Director and Technical Committee Member

Stock News
·
Oct 14

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee

GlobeNewswire
·
Oct 14

HUTCHMED (00013) to Present FRUSICA-2 Registration Study Data at 2025 European Society for Medical Oncology Annual Meeting

Stock News
·
Oct 13

HUTCHMED Announces Positive FRUSICA-2 Trial Results for Fruquintinib and Sintilimab Combo in Advanced Renal Cell Carcinoma; Data to Be Presented at 2025 ESMO Congress

Reuters
·
Oct 13

Hong Kong Stock Announcements | YUNFENG FIN: Strategic Investment in Global Cryptocurrency Life Insurance Company Anthea and Strategic Cooperation

Stock News
·
Oct 02

HUTCHMED (00013) to Present Clinical Data at 2025 European Society for Medical Oncology (ESMO) Annual Conference

Stock News
·
Oct 02

HUTCHMED Announces New Clinical Data to Be Presented at ESMO Congress 2025, Highlighting Advancements in Oncology Therapies

Reuters
·
Oct 02

HUTCHMED (China) Cut to Underweight From Equal-Weight by Morgan Stanley

Dow Jones
·
Sep 23

HUTCHMED (00013) to Present Latest R&D Progress on October 31

Stock News
·
Sep 12

HUTCHMED (China) Ltd. to Present Key R&D Updates at Upcoming Shanghai Event

Reuters
·
Sep 12

Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025

GlobeNewswire
·
Sep 12

Hong Kong Stock Movement | Innovative Drug Stocks Rise Across the Board as 2025 World Lung Cancer Congress Approaches, Institutions Bullish on Valuation Recovery Potential of Innovative Drug Sector

Stock News
·
Sep 05